Tlando is a Oral Capsule, Liquid Filled in the Human Prescription Drug category. It is labeled and distributed by Antares Pharma, Inc.. The primary component is Testosterone Undecanoate.
Product ID | 54436-112_dcd3d0e0-089f-430c-9f1a-1bbbea82e737 |
NDC | 54436-112 |
Product Type | Human Prescription Drug |
Proprietary Name | Tlando |
Generic Name | Testosterone Undecanoate |
Dosage Form | Capsule, Liquid Filled |
Route of Administration | ORAL |
Marketing Start Date | 2022-04-15 |
Marketing Category | NDA / |
Application Number | NDA208088 |
Labeler Name | Antares Pharma, Inc. |
Substance Name | TESTOSTERONE UNDECANOATE |
Active Ingredient Strength | 113 mg/1 |
Pharm Classes | Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS] |
DEA Schedule | CIII |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-04-15 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
54436-112 | Tlando | testosterone undecanoate |
67979-511 | Aveed | testosterone undecanoate |
69087-158 | Jatenzo | testosterone undecanoate |
69087-198 | Jatenzo | testosterone undecanoate |
69087-237 | Jatenzo | testosterone undecanoate |
80603-101 | Kyzatrex | TESTOSTERONE UNDECANOATE |
80603-103 | Kyzatrex | TESTOSTERONE UNDECANOATE |
80603-105 | Kyzatrex | TESTOSTERONE UNDECANOATE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TLANDO 88616780 not registered Live/Pending |
Lipocine Inc. 2019-09-13 |
TLANDO 88487154 not registered Live/Pending |
Lipocine Inc. 2019-06-24 |
TLANDO 87075975 not registered Dead/Abandoned |
Lipocine Inc. 2016-06-17 |
TLANDO 86925344 not registered Live/Pending |
Lipocine Inc. 2016-03-01 |